Troxacitabine in leukemia

Author： Swords Ronan   Apostolidou Effrosyni   Giles Francis  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.11, Iss.5-6, 2006-10, pp. : 321-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Troxacitabine in acute leukemia

By Swords R.   Giles F.  

Hematology, Vol. 12, Iss. 3, 2007-06 ,pp. : 219-227

Maney Publishing

Access to resources Recommend Favorite

Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase

By Giles F.J.   Feldman E.J.   Roboz G.J.   Larson R.A.   Mamus S.W.   Cortes J.E.   Verstovsek S.   Faderl S.   Talpaz M.   Beran M.   Albitar M.   O'Brien S.M.   Kantarjian H.M.  

Leukemia Research, Vol. 27, Iss. 12, 2003-12 ,pp. : 1091-1096

Elsevier

Access to resources Recommend Favorite

Is Friday leukemia a non-entity?

By Velázquez-Sánchez-de-Cima Sara   Zamora-Ortiz Gabriela   Rodriguez-Morales Uxmal   Ruiz-Arguelles Guillermo José  

Hematology, Vol. 18, Iss. 5, 2013-09 ,pp. : 284-285

Maney Publishing

Access to resources Recommend Favorite

Angiogenesis in Chronic Lymphocytic Leukemia

By  

Current Angiogenesis, Vol. 2, Iss. 2, 2013-09 ,pp. : 96-103

Bentham Science Publishers

Access to resources Recommend Favorite

Juvenile myelomonocytic leukemia

By Kratz Christian   Niemeyer Charlotte  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 100-103

Maney Publishing

Access to resources Recommend Favorite